Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas.
Kanaya N, Kitamura Y, Lopez Vazquez M, Franco A, Chen KS, van Schaik TA, Farzani TA, Borges P, Ichinose T, Seddiq W, Kuroda S, Boland G, Jahan N, Fisher D, Wakimoto H, Shah K.
Kanaya N, et al.
Sci Transl Med. 2023 May 31;15(698):eade8732. doi: 10.1126/scitranslmed.ade8732. Epub 2023 May 31.
Sci Transl Med. 2023.
PMID: 37256936
Free PMC article.